![Carlos von Bonhorst](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carlos von Bonhorst
Keine laufenden Positionen mehr
Karriereverlauf von Carlos von Bonhorst
Ehemalige bekannte Positionen von Carlos von Bonhorst
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Helsinn Healthcare SA
![]() Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Corporate Officer/Principal | 01.01.1985 | 01.01.1993 |
Biofarma Lda. | Corporate Officer/Principal | 01.01.1975 | 01.01.1985 |
RECIPHARM AB (PUBL) | Direktor/Vorstandsmitglied | 07.05.2015 | - |
Independent Dir/Board Member | 07.05.2015 | - |
Ausbildung von Carlos von Bonhorst
University of Lisbon | Doctorate Degree |
Statistik
International
Portugal | 3 |
Schweiz | 2 |
Schweden | 2 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Helsinn Healthcare SA
![]() Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Health Technology |
Recipharm AB
![]() Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
Biofarma Lda. |
- Börse
- Insiders
- Carlos von Bonhorst
- Erfahrung